JENNIFER FLEMING: Open Payments
NPI 1376097071 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $733 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 4 | $134 |
| GENZYME CORPORATION | 3 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Ardelyx, Inc. | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Lilly USA, LLC | 2 | $39 |
| Braintree Laboratories, Inc. | 2 | $35 |
| Mirum Pharmaceuticals, Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: DUPIXENT, VOQUEZNA, IBSRELA, OMVOH, ENTYVIO, Livmarli, IQIRVO, XIFAXAN.
Industry payments across TX — which companies pay providers there.
